Drug
Azd6714
Azd6714: highest development phase Phase 1, developed by AstraZeneca. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| AZD6714 NCT00886366 | Phase 1 | Type 2 Diabetes |
Latest
No recent events.
Follow Azd6714 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.